title: [Pharmacological vitreolysis].
abstract: Posterior vitreous detachment (PVD) is a physiological ageing process. In many cases PVD is incomplete and pathological adhesions of vitreous collagen may be associated with tractional forces in the periphery where they can cause retinal breaks and lead to detachment of the neurosensory retina. In the macular area such tractional forces at the vitreoretinal interface can contribute to the formation of specific entities such as vitreomacular traction syndrome and macular holes which are associated with an impairment of visual acuity and disturbing metamorphopsia. Currently, pars plana vitrectomy with induction of PVD, peeling of epiretinal membranes and the ILM represents an effective and safe treatment option for these conditions. Pharmacological vitreolysis is a new and alternative, non-surgical approach to release tractional forces at the vitreoretinal interface by injecting an enzyme with proteolytic activity against fibronectin and laminin into the vitreous cavity. Certain forms of vitreomacular traction and smaller macular holes can be successfully treated in this way without surgical manipulation of the retinal surface. The role of the concept of pharmacological vitreolysis as a treatment option even for exudative macular diseases or as an adjunct to assist vitreoretinal surgical procedures is currently under investigation.
authors.affiliation: Augenklinik , Ludwig-Maximilians-Universität, Mathildenstr. 8, 80336, München, Deutschland, Christos.haritoglou@med.uni-muenchen.de.
authors.forename: C
authors.initials: C
authors.lastname: Haritoglou
authors.forename: A
authors.initials: A
authors.lastname: Kampik
mesh_terms: D003131:Combined Modality Therapy; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D058449:Intravitreal Injections; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D010446:Peptide Fragments / Q000627:therapeutic use*; D011292:Premedication / Q000379:methods*; D014821:Vitrectomy / Q000379:methods*; D020255:Vitreous Detachment / Q000628:therapy*
chemical_list: D005343:Fibrinolytic Agents; D009883:Ophthalmic Solutions; D010446:Peptide Fragments
references.citation: Ophthalmology. 1998 Sep;105(9):1617-20
references.pmid: 9754166
references.citation: Invest Ophthalmol Vis Sci. 2004 Feb;45(2):641-7
references.pmid: 14744909
references.citation: Curr Eye Res. 2011 Jun;36(6):534-9
references.pmid: 21591862
references.citation: Arch Ophthalmol. 1993 Jun;111(6):849-54
references.pmid: 8512489
references.citation: Arch Ophthalmol. 2011 Mar;129(3):283-7
references.pmid: 21402982
references.citation: Dev Ophthalmol. 2009;44:1-6
references.pmid: 19494646
references.citation: Acta Ophthalmol. 2014 Feb;92(1):47-50
references.pmid: 23025384
references.citation: Ophthalmology. 2010 Apr;117(4):791-7
references.pmid: 20138368
references.citation: Retina. 2007 Oct;27(8):1074-8
references.pmid: 18040248
references.citation: J Invest Dermatol. 1989 Aug;93(2):287-90
references.pmid: 2546994
references.citation: Eye (Lond). 2008 Feb;22(2):300-7
references.pmid: 17704761
references.citation: Retina. 1998;18(1):1-3
references.pmid: 9502274
references.citation: Am J Ophthalmol. 2007 Nov;144(5):668-672
references.pmid: 17870044
references.citation: Retina. 1998;18(1):7-15
references.pmid: 9502275
references.citation: Am J Ophthalmol. 2005 Oct;140(4):585-97
references.pmid: 16226510
references.citation: N Engl J Med. 2012 Aug 16;367(7):606-15
references.pmid: 22894573
references.citation: Retina. 2000;20(2):195-8
references.pmid: 10783954
references.citation: Am J Ophthalmol. 2001 Sep;132(3):363-8
references.pmid: 11530049
references.citation: Eur J Ophthalmol. 2005 Nov-Dec;15(6):787-94
references.pmid: 16329067
references.citation: Ophthalmology. 2009 Jul;116(7):1349-55, 1355.e1-2
references.pmid: 19447497
references.citation: Invest Ophthalmol Vis Sci. 2009 Feb;50(2):814-9
references.pmid: 18806295
references.citation: Retina. 2010 Jul-Aug;30(7):1122-7
references.pmid: 20616687
references.citation: J Ocul Pharmacol Ther. 2009 Aug;25(4):379-84
references.pmid: 19650710
references.citation: Retina. 2000;20(2):126-33
references.pmid: 10783944
references.citation: Retina. 2006 Sep;26(7):792-6
references.pmid: 16963853
references.citation: Ophthalmology. 2003 Jan;110(1):62-4
references.pmid: 12511347
references.citation: Curr Eye Res. 2003 Feb;26(2):107-12
references.pmid: 12815529
references.citation: Dev Ophthalmol. 2009;44:7-19
references.pmid: 19494647
references.citation: Retina. 2008 Mar;28(3 Suppl):S75-80
references.pmid: 18317350